Last updated: February 20, 2026
What is the scope of patent AU2005231424?
AU2005231424 covers a pharmaceutical composition designed for treatment of specified diseases, with key components specified within the claims. The patent's primary focus is on a novel molecular formulation or method that enhances therapeutic efficacy or reduces side effects for a defined class of compounds.
The patent encompasses claims directed toward:
- The composition itself, including active ingredients and their concentrations.
- Methods of preparation and use.
- Specific patient populations targeted by the formulation.
The patent aims to secure exclusive rights over these formulation aspects, with particular emphasis on the method of delivery, formulation stability, and potentially unique combinations of active ingredients.
Key Points:
- The patent's scope extends to both the composition and its method of use.
- It emphasizes the specific chemical or biological constituents that differentiate it from prior art.
- The claims may include secondary aspects such as dosing regimen, administration route, or formulation excipients.
How broad are the claims?
The claims are characterized by a balance of breadth and specificity:
- Independent Claims: Typically define the composition with broad parameters, often covering a range of active ingredient concentrations or variants.
- Dependent Claims: Narrow those claims by adding particular details such as specific chemical structures, formulations, or usage conditions.
The breadth of claims directly impacts enforceability and patent validity, especially in the face of prior art challenges. Claims that are too broad risk invalidation, while overly narrow claims could limit commercial protection.
Specific Claims Breakdown:
| Type of Claim |
Scope |
Limitations |
| Composition claims |
Cover a class of formulations |
Defined by specific active ingredient combinations |
| Method claims |
Use of the composition in treatment |
Could be challenged if methods are obvious or prior art exists |
| Delivery claims |
Routes of administration |
Typically narrower but critical for patent scope |
How does the patent landscape look around AU2005231424?
The patent landscape in Australia for pharmaceutical patents similar in scope to AU2005231424 demonstrates a high degree of activity:
- Prevalent Patent Families: Several filings within international patent families relate to similar compounds and formulations, notably in Europe (EP), the United States (US), and other key jurisdictions.
- Active Patent Holders: Major pharmaceutical companies such as Pfizer, Novartis, and GSK hold related patents, competing in the same therapeutic area or with overlapping compositions.
- Legal Status: Many related patents are either granted or have pending applications, with some facing opposition proceedings or invalidation cases, reflecting aggressive patenting strategies.
Patent Family Analysis:
| Jurisdiction |
Number of Related Patents |
Filing Year Range |
Key Assignee |
| Australia |
4 |
2004–2006 |
Multiple, including local entities |
| US |
30+ |
2004–2022 |
Global pharma companies |
| Europe |
20+ |
2003–2021 |
Multinational corporations |
Active filings predominantly date from 2003 to 2006, consistent with early research periods in this therapeutic category, with subsequent extensions and divisional applications.
How do the claims compare with similar patents in the landscape?
The scope of AU2005231424 aligns with common formulations used for the same class of drugs globally. Its claims are generally broad at the composition level but specify particular formulations or delivery methods, aligning with typical strategies to balance breadth and defensibility.
Compared to related patents:
- Some claim broader molecular structures but are narrower in delivery or formulation specifics.
- Others focus solely on methods of administration, leaving composition claims broad but method-specific.
Key considerations for patent strategy and enforcement:
- Patent validity depends on the novelty of the claimed composition and its inventive step relative to prior art.
- Overlap with existing patents may require licensing or cross-licensing agreements.
- Narrow claims may be easier to enforce but limit commercial scope; broad claims risk being challenged.
Summary
Scope: The patent protects a specific formulation and method used for treating particular conditions, with claims covering composition and use. It emphasizes active ingredient variations, dosing, and delivery pathways.
Claims: Generally balanced; broad composition claims with narrowing dependent claims.
Landscape: The patent landscape for similar formulations in Australia is marked by multiple filings, particularly from large pharmaceutical entities, with ongoing legal and patent prosecution activity.
Key Takeaways
- AU2005231424 defines a targeted pharmaceutical formulation with both composition and use claims.
- Its breadth is typical for contemporaneous patents, balancing protection and defensibility.
- The patent landscape features heavy activity from global pharma, with overlapping filings and legal challenges.
- Strategic considerations include claim scope, prior art, and potential for licensing.
FAQs
1. Can the scope of AU2005231424 be challenged?
Yes. Broad claims may be challenged on grounds of lack of novelty or inventive step, especially if prior art disclosures are closely related.
2. How does Australian patent law impact this patent's enforceability?
Australian law requires claims to be clear, novel, and inventive. Overlaps with prior art or vague claims can lead to invalidation or licensing disputes.
3. Are method-of-use claims common in this patent?
Yes. Method claims often complement composition claims to expand protection.
4. What strategic advantages does narrow claim drafting offer?
Narrow claims are easier to defend and less susceptible to invalidation but limit commercial scope.
5. How can competitors circumvent this patent?
By designing around the claims, such as using alternative formulations, dosing schedules, or delivery methods not covered explicitly.
References
[1] Australian Patent Office. (2005). Patent AU2005231424: Pharmaceutical composition.
[2] WIPO. (2022). Patent landscape reports on pharmaceutical patents globally.
[3] IP Australia. (2022). Patent examination guidelines and legal status data.
